| Application no. and date | 19153389.2 (espacenet) (Federated) (European Patent Register), 20140313 | | Patent/reg. no. and date | DK/EP 3514157, 20230906 | | Publication date | 20190724 | | Priority no. and date | US 201361791913 P, 20130315 | | EP pub. no. and date |
EP 3514157 20190724 | | Effective date | | | Applicant/owner | Genzyme Corporation, 450 Water Street
Cambridge, MA 02141, US | | Applicant ref. no. | 1678597 | | Inventor | SIEGEL, Craig, c/o Sanofi U.S.,
55 Corporate Drive
Bridgewater, New Jersey 08807, US,
GIMI, Rayomand, c/o Sanofi U.S.,
55 Corporate Drive
Bridgewater, New Jersey 08807, US,
REARDON, Michael, c/o Sanofi U.S.,
55 Corporate Drive
Bridgewater, New Jersey 08807, US,
ZHAO, Jin, c/o Sanofi U.S.,
55 Corporate Drive
Bridgewater, New Jersey 08807, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61P 3/00 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C07D 277/30 (2006.01) , C07D 417/06 (2006.01) , C07D 417/12 (2006.01) , C07D 453/02 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF GLUCOSYLCERAMIDSYNTHASE-HÆMMERE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
